Xiaoli Shan
Impact in
-
- Traditional Chinese Medicine Analysis
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
Papers in
-
- Signaling Pathways in Disease 6
- Ginseng Biological Effects and Applications 2
-
- Cardiac Fibrosis and Remodeling 7
- Cardiac electrophysiology and arrhythmias 3
- Co-authors
- Pei Zhao (18 shared papers)Rong Lü (17 shared papers)Wei Guo (16 shared papers)Chen Zhang (14 shared papers)Ming Xu (13 shared papers)Huihua Chen (16 shared papers)Jing Tian (5 shared papers)Tongtong Cao (2 shared papers)
In The Last Decade
Xiaoli Shan
21 papers receiving 375 citations
Peers
Comparison fields: 5 of 79
- Complementary and alternative medicine 49
- Cardiology and Cardiovascular Medicine 97
- Pharmacology 33
- Molecular Biology 206
- Pathology and Forensic Medicine 50
Countries citing papers authored by Xiaoli Shan
This map shows the geographic impact of Xiaoli Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Shan more than expected).
Fields of papers citing papers by Xiaoli Shan
This network shows the impact of papers produced by Xiaoli Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Shan. The network helps show where Xiaoli Shan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 96 | |
| 2 | 2021 | 43 | |
| 3 | 2019 | 37 | |
| 4 | 2018 | 33 | |
| 5 | 2014 | 33 | |
| 6 | 2019 | 23 | |
| 7 | 2023 | 19 | |
| 8 | 2020 | 16 | |
| 9 | 2022 | 11 | |
| 10 | Stachydrine hydrochloride ameliorates cardiac hypertrophy through CaMKII/HDAC4/MEF2C signal pathway. | 2022 | 10 |
| 11 | 2023 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2023 | 2 |
About Xiaoli Shan
Xiaoli Shan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine, Physiology and Oncology, having authored 22 papers that have together received 377 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (7 papers), Signaling Pathways in Disease (6 papers), Cardiac Ischemia and Reperfusion (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Ginseng Biological Effects and Applications (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Traditional Chinese Medicine Analysis (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Complementary and alternative medicine (49 citations), Cardiology and Cardiovascular Medicine (97 citations), Pharmacology (33 citations), Molecular Biology (206 citations) and Pathology and Forensic Medicine (50 citations). Xiaoli Shan has collaborated with scholars based in China, Hong Kong and Portugal. Frequent co-authors include Pei Zhao, Rong Lü, Wei Guo, Chen Zhang, Ming Xu, Huihua Chen, Jing Tian, Tongtong Cao, Ke Ning and Yachao Wang. Their work appears in journals such as European Journal of Pharmacology, Journal of Ethnopharmacology, Frontiers in Pharmacology, International Journal of Molecular Sciences and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.